Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma.
Ziqing TangGeting WuFang TanYang LongJidong HongZhiping LyuRui WeiPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
On the basis of this study, we propose that PCNSL patients should receive early induction therapy with sufficient cycles. Subsequent consolidation therapy can prevent relapses and improve survival. In patients with PCNSL, the independent prognostic factors for OS and PFS were CSF LDH level, NLR, and full cycles of induction therapy.